Zobrazeno 1 - 10
of 155
pro vyhledávání: '"James F. Pingpank"'
Autor:
Ahmad Tarhini, Yan Lin, Huang Lin, Zahra Rahman, Priyanka Vallabhaneni, Prateek Mendiratta, James F. Pingpank, Matthew P. Holtzman, Erik C. Yusko, Julie A. Rytlewski, Uma N. M. Rao, Robert L. Ferris, John M. Kirkwood
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background Neoadjuvant immunotherapy utilizing novel combinations has the potential to transform the standard of care for locally/regionally advanced melanoma. We hypothesized that neoadjuvant ipilimumab in combination with high dose IFNα2b
Externí odkaz:
https://doaj.org/article/e03efef202fb49679c2f6f0f0947635e
Autor:
Mohamed A. Adam, Helen Zhou, Jonathan Byrd, Anya L. Greenberg, Yvonne M. Kelly, Lauren Hall, Heather L. Jones, James F. Pingpank, Zachary C. Lipton, David L. Bartlett, Haroon M. Choudry
Publikováno v:
Annals of Surgical Oncology.
Autor:
Ahmed B. Hamed, Yongli Shuai, Joshua Derby, Matthew P. Holtzman, Melanie Ongchin, David L. Bartlett, James F. Pingpank, Reetesh Pai, Aatur Singhi, Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology.
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Treatment significantly affects the circulating immune compartment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eeb4ff31ce1f39f892e656546912333
https://doi.org/10.1158/1078-0432.22481585
https://doi.org/10.1158/1078-0432.22481585
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Representative gating strategy illustrating (A) CD4 and CD8 T cell identification (B) expression of ICOS on CD4 positive T cells (C) expression of PD-1 and Ki-67 within PD-1 positive cells and (D) expression of CD38/HLA-DR, PD-1 and KI-67 within CD8+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05be2d07b58f4dfd685805c3833c030c
https://doi.org/10.1158/1078-0432.22481579.v1
https://doi.org/10.1158/1078-0432.22481579.v1
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Treatment significantly affects the circulating immune compartment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf8661283efc187904b5f5fcda67641
https://doi.org/10.1158/1078-0432.22481576.v1
https://doi.org/10.1158/1078-0432.22481576.v1
Data from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Purpose:Neoadjuvant immunotherapy may improve the clinical outcome of regionally advanced operable melanoma and allows for rapid clinical and pathologic assessment of response. We examined neoadjuvant pembrolizumab and high-dose IFNα-2b (HDI) therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1471b78d10ef705c6b751e83f0d0d685
https://doi.org/10.1158/1078-0432.c.6530735.v1
https://doi.org/10.1158/1078-0432.c.6530735.v1
Autor:
Herbert J. Zeh, Shikhar Uttam, Alessandro Paniccia, Melissa E. Hogg, Kevin McGrath, Adam Slivka, Vikram C. Gorantla, Rohit Das, Katelyn Smith, Roby Antony Thomas, Asif Khalid, Michael S. Landau, Kenneth E. Fasanella, Natalie Seiser, James F. Pingpank, Harkirat Singh, Nathan Bahary, Patrick Henn, Kenneth K. Lee, Brian K. Theisen, Melanie Ongchin, Savreet Sarkaria, Randall E. Brand, Aatur D. Singhi, Brian A. Boone, Amer H. Zureikat, Susannah G. Ellsworth, N. Paul Ohori, Anil K. Dasyam, Jennifer Chennat, Susan Shyu, John C. Rhee
Publikováno v:
Clin Gastroenterol Hepatol
BACKGROUND & AIMS: The assessment of therapeutic response after neoadjuvant treatment and pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) has been an ongoing challenge. Several limitations have been encountered when employing current gradi
Autor:
Caroline J. Rieser, Jurgis Alvikas, Heather Phelos, Lauren B. Hall, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology. 29:2630-2639
Autor:
Amer H. Zureikat, Alessandro Paniccia, James F. Pingpank, Samer AlMasri, Stacy J. Kowalsky, Haroon A. Choudry, Ibrahim Nassour
Publikováno v:
Annals of Surgical Oncology. 28:8916-8925
BACKGROUND Appendiceal goblet cell adenocarcinomas (GCC) are rare tumors with clinical behavior between classic carcinoids and adenocarcinomas. Current guidelines recommend right hemicolectomy for all GCCs. PATIENTS AND METHODS The National Cancer Da